DE SANTIS, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 1.260
AS - Asia 774
EU - Europa 695
SA - Sud America 178
AF - Africa 11
OC - Oceania 1
Totale 2.919
Nazione #
US - Stati Uniti d'America 1.205
SG - Singapore 332
RU - Federazione Russa 229
IT - Italia 175
BR - Brasile 148
VN - Vietnam 115
CN - Cina 102
BD - Bangladesh 74
DE - Germania 72
HK - Hong Kong 69
FI - Finlandia 41
FR - Francia 36
GB - Regno Unito 33
CA - Canada 29
NL - Olanda 24
IN - India 18
MX - Messico 18
AT - Austria 16
AR - Argentina 14
ES - Italia 14
IE - Irlanda 11
PL - Polonia 11
JP - Giappone 10
IQ - Iraq 7
TR - Turchia 7
UZ - Uzbekistan 7
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
SE - Svezia 5
VE - Venezuela 5
CO - Colombia 4
KZ - Kazakistan 4
UA - Ucraina 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
KE - Kenya 3
PT - Portogallo 3
RS - Serbia 3
BE - Belgio 2
CL - Cile 2
EG - Egitto 2
GT - Guatemala 2
HU - Ungheria 2
ID - Indonesia 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
TH - Thailandia 1
Totale 2.919
Città #
Dallas 439
Singapore 214
San Jose 164
Council Bluffs 94
Ashburn 91
Hong Kong 64
Santa Clara 47
Ho Chi Minh City 41
The Dalles 35
Munich 33
New York 33
Hanoi 30
Los Angeles 28
Verona 28
Beijing 26
Moscow 24
Boardman 23
Lauterbourg 21
Lappeenranta 19
São Paulo 18
Benevento 15
Montreal 14
Hefei 12
Helsinki 12
Dublin 11
Mexico City 11
Poplar 11
Toronto 11
Turku 10
Warsaw 10
Brooklyn 9
Falkenstein 9
L’Aquila 9
Rome 9
Da Nang 8
Düsseldorf 8
London 8
Orem 8
Tokyo 8
Denver 7
Florence 7
Kitzingen 7
Vienna 7
Atlanta 6
Boston 6
Curitiba 6
Frankfurt am Main 6
Seattle 6
Shanghai 6
Tashkent 6
Ankara 5
Charlotte 5
Chennai 5
Chicago 5
Jinan 5
Portsmouth 5
Amsterdam 4
Bologna 4
Campinas 4
Changsha 4
Haiphong 4
Houston 4
Milan 4
Mumbai 4
Phoenix 4
Querétaro 4
Rio de Janeiro 4
Stockholm 4
Thái Nguyên 4
West Jordan 4
Annapolis 3
Braga 3
Catania 3
Fort Worth 3
Johannesburg 3
Lahore 3
Manchester 3
Nairobi 3
Naples 3
Olomouc 3
Piscataway 3
Raleigh 3
Santo André 3
Spoltore 3
St Louis 3
Teramo 3
Thái Bình 3
Agropoli 2
Aparecida 2
Astana 2
Bauru 2
Belgrade 2
Brno 2
Brussels 2
Buffalo 2
Bắc Ninh 2
Can Tho 2
Caserta 2
Concord 2
Franca 2
Totale 1.898
Nome #
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 353
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 133
Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 121
Do antithrombotic drugs have a role in migraine prevention? A systematic review 112
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 105
Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study 101
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial 101
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 98
A REAl-life study on short-term Dual Antiplatelet treatment in Patients with ischemic stroke or Transient ischemic attack (READAPT) 98
Effectiveness and tolerability of atogepant in the prevention of migraine: A real life, prospective, multicentric study (the STAR study) 97
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 95
Association of anti‐calcitonin gene‐related peptide with other monoclonal antibodies for different diseases: A multicenter, prospective, cohort study 95
Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis 94
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 93
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 89
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 88
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 87
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 84
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 82
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 79
Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10 years in a population-based stroke registry 78
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 78
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 72
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 65
A call for academic pragmatic clinical trials to address open questions in migraine prevention 64
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study 63
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 57
Migraine with aura, thrombophilia, and the debate on white matter hyperintensities 52
Clinical characteristics and outcomes of ischemic stroke despite appropriate oral anticoagulation for atrial fibrillation: A systematic review and meta-analysis of real-world studies 48
Acute Treatment of Disabling and Nondisabling Minor Ischemic Stroke: Expert Guidance for Clinicians 34
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study 31
The potential role of sleep quality in the relationship between glymphatic function and migraine frequency: Insights from a cross-sectional study 30
Atrial fibrillation detection after Embolic Stroke of Undetermined Source: development and validation of the CATCH-AF score 24
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study 22
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation 9
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke 9
null 7
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis 5
Translation and validation of the Migraine Interictal Burden Scale (MIBS-4) in an Italian clinical cohort 5
Timing of insertable cardiac monitor implantation after embolic stroke of undetermined source and its impact on atrial fibrillation detection: A target trial emulation analysis 5
Totale 2.963
Categoria #
all - tutte 10.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202318 0 0 0 0 0 0 0 1 10 1 3 3
2023/202469 2 2 5 5 3 8 0 4 2 13 3 22
2024/2025665 20 5 32 35 59 48 89 50 137 48 77 65
2025/20262.211 74 405 147 272 203 105 211 96 166 276 159 97
Totale 2.963